Back to top
more

Teladoc Health (TDOC)

(Delayed Data from NYSE)

$13.73 USD

13.73
8,060,920

-0.01 (-0.07%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $13.70 -0.03 (-0.22%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for TDOC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Teladoc Health, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 1,124 918 896 787 517
Receivables 217 211 169 169 57
Notes Receivable 0 0 0 0 0
Inventories 30 56 73 57 0
Other Current Assets 118 130 87 47 14
Total Current Assets 1,489 1,315 1,225 1,060 588
Net Property & Equipment 32 30 27 29 10
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 2,751 2,910 16,414 16,602 972
Deposits & Other Assets 80 49 21 18 7
Total Assets 4,392 4,345 17,735 17,755 1,603
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 44 48 47 46 9
Current Portion Long-Term Debt 0 0 0 43 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 281 250 195 178 81
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 96 102 89 66 0
Total Current Liabilities 421 400 331 333 90
Mortgages 0 0 0 0 0
Deferred Taxes/Income 63 55 80 105 22
Convertible Debt 1,539 1,535 1,226 1,380 440
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 10 11 12 12
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2,066 2,038 1,689 1,871 589
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 17,592 17,359 17,473 16,858 1,539
Retained Earnings -15,229 -15,008 -1,421 -993 -508
Other Equity -37 -43 -6 19 -17
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 2,326 2,308 16,046 15,884 1,014
Total Liabilities & Shareholder's Equity 4,392 4,345 17,735 17,755 1,603
Total Common Equity 2,326 2,308 16,046 15,884 1,014
Shares Outstanding 165.50 161.90 160.00 144.90 72.30
Book Value Per Share 14.05 14.25 100.29 109.62 14.03

Fiscal Year End for Teladoc Health, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 1,124 1,031 959 889
Receivables NA 217 206 215 216
Notes Receivable NA 0 0 0 0
Inventories NA 30 36 34 46
Other Current Assets NA 118 115 113 136
Total Current Assets NA 1,489 1,387 1,321 1,287
Net Property & Equipment NA 32 33 30 30
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 2,751 2,801 2,857 2,889
Deposits & Other Assets NA 80 74 73 64
Total Assets NA 4,392 4,328 4,316 4,309
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 44 26 16 39
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 281 277 260 236
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 96 99 107 107
Total Current Liabilities NA 421 403 383 381
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 63 57 62 55
Convertible Debt NA 1,539 1,538 1,537 1,536
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 2 2 10
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2,066 2,034 2,021 2,018
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 17,592 17,535 17,476 17,410
Retained Earnings NA -15,229 -15,200 -15,143 -15,078
Other Equity NA -37 -42 -39 -41
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 2,326 2,294 2,295 2,291
Total Liabilities & Shareholder's Equity NA 4,392 4,328 4,316 4,309
Total Common Equity 0 2,326 2,294 2,295 2,291
Shares Outstanding 167.00 165.50 165.50 164.90 163.60
Book Value Per Share 0.00 14.05 13.86 13.92 14.01